Por que acesso antecipado?

"This game is planned with a relatively large scope and will become a classic Eastern ARPG including all elements that you wish for a Chinese fantasy game. The features including the English version of the game with English version of spells. You will be able to create your own Fabao(法宝), it can be used both as a weapon and ride to fly. Also, more challenges and more types of enemies are going to be added in the future.
And after you've finished all the content we created ourselves, there will be an editor in-game for you to build your own enemy and spells.
This comes with great complexity and a huge amount of man-hours.

We're a very small team and we need your help to finish all these works in our plan.
That's where we need you, the community, to help us prioritize features and iron out the gameplay wrinkles."

Por quanto tempo aproximadamente este jogo estará em acesso antecipado?

"The game is planned to stay in early access for about 6 ~ 9 months."

Como a versão completa será diferente da versão de acesso antecipado?

"The features are planned:
English language
More ways to build your character
More spells and enemies.
Weapons."

Qual é o estado atual da versão de acesso antecipado?

"There will be the newest content update always in the description on the store page.

Until the end of this January, the game has complete Chinese audio recognition, direct shoot spell, shields, AOE spells, melee and ranged enemies, and five different levels with the changeable enemy amount."

O preço do jogo será alterado após o fim do acesso antecipado?

"We plan to gradually raise the price as we ship new content and features."

Como vocês planejam envolver a comunidade durante o processo de desenvolvimento?

"During the game development process, any suggestions are very welcomed. You may comment on the store page or in the Steam community. Also in the future, we are plan to open our public account on Youtube, Bilibili, and Weibo. There will be the newest content updates, and any comment is welcomed. Your comment may directly lead us to develop future content."